UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER
SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR
SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 0-19560
Athena Neurosciences, Inc.
- ----------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
800 Gateway Boulevard, South San Francisco, California 94080, (415) 877-0900
- ----------------------------------------------------------------------------
(Address, including zip code, and telephone number, including
area code, of registrant's principal executive offices)
Common Stock, par value $.01 per share
- ----------------------------------------------------------------------------
(Title of each class of securities covered by this Form)
None
- ----------------------------------------------------------------------------
(Titles of all other classes of securities for which a duty to
file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the
appropriate rule provision(s) relied upon to terminate or suspend
the duty to file reports:
Rule 12g-4(a)(1)(i) /_X_/ Rule 12h-3(b)(1)(i) /__/
Rule 12g-4(a)(1)(ii) /__/ Rule 12h-3(b)(1)(ii) /__/
Rule 12g-4(a)(2)(i) /__/ Rule 12h-3(b)(2)(i) /__/
Rule 12g-4(a)(2)(ii) /__/ Rule 12h-3(b)(2)(ii) /__/
Rule 15d-6 /__/
Approximate number of holders of record as of the
certification or notice date: 1(one)
------------------------------------------
Pursuant to the requirements of the Securities Exchange Act of
1934, Athena Neurosciences, Inc. has caused this
certification/notice to be signed on its behalf by the
undersigned duly authorized person.
Date: July 2, 1996 By: Lisabeth F. Murphy
-------------- -------------------------------
Lisabeth F. Murphy, Counsel for
the registrant
